Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Soligenix (SNGX)
NASDAQ:SNGX
Soligenix (SNGX) Stock Price & Analysis
563 Followers
SNGX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.38 - $4.20
Previous Close$0.6
Volume137.61K
Average Volume (3M)1.23M
Market Cap
$6.31M
Enterprise Value$9.81M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$3.49M
Price to Earnings (P/E)-0.7
Beta0.70
Next Earnings
May 13, 2024EPS Estimate
-$0.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.92
Shares Outstanding10,524,437
10 Day Avg. Volume83,404
30 Day Avg. Volume1,233,711
Standard Deviation0.31
R-Squared0.10
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)2.53
Price to Sales (P/S)7.52
Price to Cash Flow (P/CF)-0.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue9.12
Enterprise Value/Gross Profit100.80
Enterprise Value/Ebitda-1.16
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Soligenix News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SNGX FAQ
What was Soligenix’s price range in the past 12 months?
Soligenix lowest stock price was $0.38 and its highest was $4.20 in the past 12 months.
What is Soligenix’s market cap?
Currently, no data Available
When is Soligenix’s upcoming earnings report date?
Soligenix’s upcoming earnings report date is May 13, 2024 which is in 19 days.
How were Soligenix’s earnings last quarter?
Soligenix released its earnings results on Mar 15, 2024. The company reported -$0.05 earnings per share for the quarter, beating the consensus estimate of -$0.2 by $0.15.
Is Soligenix overvalued?
According to Wall Street analysts Soligenix’s price is currently Overvalued.
Does Soligenix pay dividends?
Soligenix does not currently pay dividends.
What is Soligenix’s EPS estimate?
Soligenix’s EPS estimate is -$0.2.
How many shares outstanding does Soligenix have?
Soligenix has 10,524,437 shares outstanding.
What happened to Soligenix’s price movement after its last earnings report?
Soligenix reported an EPS of -$0.05 in its last earnings report, beating expectations of -$0.2. Following the earnings report the stock price went down -3.125%.
Which hedge fund is a major shareholder of Soligenix?
Currently, no hedge funds are holding shares in SNGX
---
Soligenix Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-72.09%
12-Months-Change
Fundamentals
Return on Equity
-9999.00%
Trailing 12-Months
Asset Growth
-31.39%
Trailing 12-Months
Company Description
Soligenix
Soligenix, Inc. engages in the development and commercialization of products to treat rare disease. It operates through the following segments: BioTherapeutics and Vaccines/BioDefense. The BioTherapeutics segment offers photodynamic therapy (SGX301) utilizing topical synthetic hypericin activated with safe visible fluorescent light for the treatment of cutaneous T-cell lymphoma. The Vaccines/BioDefense segment includes active development programs for RiVax, ricin toxin vaccine candidate, OrbeShield, GI acute radiation syndrome therapeutic candidate, and SGX943, melioidosis therapeutic candidate. The company was founded in 1987 and is headquartered Princeton, NJ.
---
SNGX Stock 12 Months Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering SNGX
1 Year
1 Year Success Rate
0/3 ratings generated profit
1 Year Average Return
-25.90%
reiterated a buy rating 11 months ago
Copying James Molloy's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -25.90% per trade.
---